IRIS Accounts Production v26.3.0.614 08001193 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080011932025-03-31080011932026-03-31080011932025-04-012026-03-31080011932024-03-31080011932024-04-012025-03-31080011932025-03-3108001193ns15:EnglandWales2025-04-012026-03-3108001193ns14:PoundSterling2025-04-012026-03-3108001193ns10:Director12025-04-012026-03-3108001193ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3108001193ns10:SmallEntities2025-04-012026-03-3108001193ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3108001193ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3108001193ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3108001193ns10:FullAccounts2025-04-012026-03-3108001193ns10:OrdinaryShareClass22025-04-012026-03-3108001193ns10:OrdinaryShareClass32025-04-012026-03-3108001193ns10:OrdinaryShareClass42025-04-012026-03-3108001193ns10:OrdinaryShareClass52025-04-012026-03-3108001193ns10:Director22025-04-012026-03-3108001193ns10:RegisteredOffice2025-04-012026-03-3108001193ns5:CurrentFinancialInstruments2026-03-3108001193ns5:CurrentFinancialInstruments2025-03-3108001193ns5:Non-currentFinancialInstruments2026-03-3108001193ns5:Non-currentFinancialInstruments2025-03-3108001193ns5:ShareCapital2026-03-3108001193ns5:ShareCapital2025-03-3108001193ns5:RetainedEarningsAccumulatedLosses2026-03-3108001193ns5:RetainedEarningsAccumulatedLosses2025-03-3108001193ns5:MotorVehicles2025-04-012026-03-3108001193ns5:ComputerEquipment2025-04-012026-03-3108001193ns5:MotorVehicles2025-03-3108001193ns5:ComputerEquipment2025-03-3108001193ns5:MotorVehicles2026-03-3108001193ns5:ComputerEquipment2026-03-3108001193ns5:MotorVehicles2025-03-3108001193ns5:ComputerEquipment2025-03-3108001193ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3108001193ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108001193ns5:CurrentFinancialInstruments2025-04-012026-03-3108001193ns5:DeferredTaxation2025-03-3108001193ns5:DeferredTaxation2025-04-012026-03-3108001193ns5:DeferredTaxation2026-03-3108001193ns10:OrdinaryShareClass22026-03-3108001193ns10:OrdinaryShareClass32026-03-3108001193ns10:OrdinaryShareClass42026-03-3108001193ns10:OrdinaryShareClass52026-03-3108001193ns10:Director112025-03-3108001193ns10:Director112024-03-3108001193ns10:Director112025-04-012026-03-3108001193ns10:Director112024-04-012025-03-3108001193ns10:Director112026-03-3108001193ns10:Director112025-03-31
REGISTERED NUMBER: 08001193 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

FOR

WHEELER SCIENCE MEDICINE & EDUCATION LTD

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WHEELER SCIENCE MEDICINE & EDUCATION LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DIRECTORS: D W Wheeler
S J Wheeler





REGISTERED OFFICE: c/o TC Thompson Taraz Rand
Suite 20, New Cambridge House
Bassingbourn Road
Litlington
Cambridgeshire
SG8 0SS





BUSINESS ADDRESS: Heatherlea
Carnoch
Glencoe
Bellachulish
Argyll
PH49 4HQ





REGISTERED NUMBER: 08001193 (England and Wales)





ACCOUNTANTS: TC Group
1st Floor
5-7 Portugal Place
Cambridge
Cambridgeshire
CB5 8AF

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

BALANCE SHEET
31 MARCH 2026

2026 2025
Notes £    £   
FIXED ASSETS
Tangible assets 5 111,360 86,901

CURRENT ASSETS
Debtors 6 91,645 109,578
Cash and cash equivalents 15,534 35,609
107,179 145,187
CREDITORS
Amounts falling due within one year 7 (53,384 ) (32,456 )
NET CURRENT ASSETS 53,795 112,731
TOTAL ASSETS LESS CURRENT LIABILITIES 165,155 199,632

CREDITORS
Amounts falling due after more than one
year

8

(71,585

)

(44,620

)

PROVISIONS FOR LIABILITIES 11 (30,589 ) (21,725 )
NET ASSETS 62,981 133,287

CAPITAL AND RESERVES
Called up share capital 12 100 100
Retained earnings 62,881 133,187
SHAREHOLDERS' FUNDS 62,981 133,287

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

BALANCE SHEET - continued
31 MARCH 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 October 2026 and were signed on its behalf by:





D W Wheeler - Director


WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1. STATUTORY INFORMATION

Wheeler Science Medicine & Education Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Revenue recognition
Turnover shown in the profit and loss account represents the invoiced sales in relation to the provision of medical consultancy services.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Motor vehicles - 25% on reducing balance
Equipment - 33.33% on cost

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any.

Financial instruments
Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2025 - 4 ) .

5. TANGIBLE FIXED ASSETS
Motor
vehicles Equipment Totals
£    £    £   
COST
At 1 April 2025 124,179 16,955 141,134
Additions 62,321 - 62,321
At 31 March 2026 186,500 16,955 203,455
DEPRECIATION
At 1 April 2025 41,935 12,298 54,233
Charge for year 36,141 1,721 37,862
At 31 March 2026 78,076 14,019 92,095
NET BOOK VALUE
At 31 March 2026 108,424 2,936 111,360
At 31 March 2025 82,244 4,657 86,901


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 72,790 50,892
Amounts owed by associates 2,758 14,942
Other debtors 16,097 42,851
Directors' current accounts - 893
91,645 109,578

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Hire purchase contracts (see note 9) 26,026 14,870
Trade creditors 998 55
Corporation tax 1,669 -
Social security and other taxes - 84
VAT 19,176 15,877
Directors' current accounts 3,865 -
Accrued expenses 1,650 1,570
53,384 32,456

The directors' current accounts are repayable on demand and interest free.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2026 2025
£    £   
Hire purchase contracts (see note 9) 71,585 44,620

9. LEASING AGREEMENTS

Assets held under finance leases, which are leases where substantially all the risks and rewards of ownership have passed to the company, are capitalised in the balance sheet as a tangible fixed asset and are depreciated over the shorter of the lease term and their useful lives. The capital elements of future obligations under the leases are included as liabilities in the balance sheet. The interest element of the rental obligation is charged to the profit and loss account.

10. SECURED DEBTS

The following secured debts are included within creditors:

2026 2025
£    £   
Hire purchase contracts 97,611 59,490

Liabilities held under hire purchase agreements are secured against the asset to which they relate.

11. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax 30,589 21,725

Deferred
tax
£   
Balance at 1 April 2025 21,725
Provided during year 8,864
Charge for the year
Balance at 31 March 2026 30,589

The provision for deferred taxation is made up of accelerated capital allowances.

12. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
55 Ordinary A £1 55 55
30 Ordinary B £1 30 30
5 Ordinary C £1 5 5
5 Ordinary D £1 5 5
5 Ordinary E £1 5 5
100 100

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

13. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2026 and 31 March 2025:

2026 2025
£    £   
D W Wheeler
Balance outstanding at start of year 893 3,386
Amounts advanced - 893
Amounts repaid (893 ) (3,386 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 893

14. RELATED PARTY DISCLOSURES

At the balance sheet date, the director had an outstanding director's loan account balance of £Nil (2025: £893) which is disclosed in other debtors. This amount bears no interest and there is no agreed repayable date.


At the balance sheet date, the company was owed £2,758 from Brooks and Wren Properties Ltd, which is also under control of the director. This amount bears no interest and there is no agreed repayable date.